Magnetic Temperature-Sensitive Solid-Lipid Particles for Targeting and Killing Tumor Cells.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Solid lipid particles (SLPs) are a promising drug delivery system.
• Magnetic nanoparticles offer potential for targeted therapy and hyperthermia.
• Drug resistance remains a significant challenge in cancer treatment.

Purpose of the Study:

• To develop and characterize magnetic and temperature-sensitive solid lipid particles (mag. SLPs).
• To evaluate the cytotoxic activity of mag. SLPs against various human cancer cell lines, including drug-resistant ones.
• To elucidate the mechanism of mag. SLPs-induced cell death.

Main Methods:

• Preparation and characterization of mag. SLPs using iron oxide nanoparticles, 1-tetradecanol, and poly(ethylene oxide)-block-poly(ε-caprolactone).
• Assessment of cytotoxicity using trypan blue exclusion and MTT assays on Jurkat, HL-60/wt, HL-60 sublines, and U251 cells.
• Analysis of cell death mechanisms via Hoechst 33342/PI staining, Western blot, DNA fragmentation assays, and FACS analysis.
• Measurement of reactive oxygen species (ROS) levels.

Main Results:

• Mag. SLPs exhibited dose-dependent cytotoxicity against leukemia and glioblastoma cell lines, outperforming doxorubicin in resistant lines.
• Treatment induced both apoptosis (condensed chromatin, fragmented nuclei) and necrosis (plasma membrane blebbing).
• Mag. SLPs significantly increased reactive oxygen species (ROS) production in cancer cells, suggesting a key role in cytotoxicity.

Conclusions:

• Developed mag. SLPs demonstrate effective killing of human tumor cells, including drug-resistant phenotypes.
• The particles induce cell death through both apoptotic and necrotic pathways, potentially mediated by ROS generation.
• Mag. SLPs represent a viable therapeutic strategy for challenging cancer types.